Thymosin Alpha-1 10mg Spray is a research-grade synthetic 28-amino-acid peptide immunomodulator formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Functioning as a stable analog of endogenous thymic peptide, Thymosin Alpha-1 (sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH) is studied for its ability to bind Toll-like receptors (TLR4 and TLR9), stimulating dendritic cell maturation and T-cell differentiation. Formulated as a stabilized solution, each bottle contains 10mg total active peptide, analytically verified by HPLC to support reproducible scientific investigations.
HPLC certified
Independent analysis
Highest standard
Full traceability
Thymosin Alpha-1 10mg Spray is a synthetic 28-amino-acid thymic peptide solution designed to evaluate non-invasive mucosal transport kinetics and localized immune pathway activation. As a potent immunomodulator, Thymosin Alpha-1 binds Toll-like receptors (TLR4/TLR9) on dendritic cells, activating nuclear factor-kappa B (NF-kB) pathways to stimulate Th1 cytokine production (specifically IFN-gamma, IL-2, and TNF-alpha). Unlike standard lyophilized powders that require reconstitution, this spray format provides a concentration-verified, pre-dissolved liquid format calibrated for precise laboratory assays.
Researchers continue to investigate Thymosin Alpha-1 across major areas of immunology and oncology, including dendritic cell maturation, natural killer (NK) cell activation, viral replication suppression, and MHC Class I expression kinetics. The intranasal spray formulation is of exceptional scientific interest because it allows researchers to study epithelial membrane transport kinetics of larger peptides and localized immune cell receptor binding in nasal-associated lymphoid tissue (NALT) without systemic variables. Formulated with high-purity research-grade materials, Thymosin Alpha-1 10mg Spray is a specialized molecular tool for laboratories examining immune regulation and peptide delivery kinetics under controlled conditions.
Thymosin Alpha-1 10mg Spray is a research-grade synthetic peptide solution developed for laboratory investigations involving neuroimmunology, receptor kinetics, and non-invasive delivery methods. Chemically classified as a synthetic thymic peptide derived from prothymosin alpha, it comprises 28 amino acid residues with the sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, featuring an acetylated N-terminus. As an investigational compound, Thymosin Alpha-1 is studied for its ability to activate Toll-like receptors, modulating downstream immune cascades.
From a molecular research perspective, Thymosin Alpha-1 Spray provides a valuable model for investigating the transport kinetics of immunomodulatory peptides across epithelial cell layers. Standard peptide studies frequently depend on parenteral routes; however, liquid spray preparations enable researchers to evaluate how medium-sized peptides cross mucosal membranes, interact with tight junctions, and engage localized cellular receptors in lymphoid tissues. This spray format is particularly suited for research involving nasal mucosal cell lines.
Current laboratory investigations examine Thymosin Alpha-1's interaction with Toll-like receptors (TLR4 and TLR9) on antigen-presenting cells (APCs). Receptor binding activates the MyD88-dependent intracellular signaling cascade, triggering nuclear translocation of NF-kB. This transcriptional activation stimulates the upregulation of MHC Class I molecules, CD80/CD86 co-stimulatory molecules, and the secretion of Th1 cytokines (IFN-gamma, TNF-alpha, and IL-2). Researchers analyze these pathways to characterize immune-modulatory thresholds under controlled conditions.
Beyond cytokine regulation, researchers use Thymosin Alpha-1 to explore natural killer (NK) cell activation and cellular cytotoxicity. Studies evaluate how exposure to the peptide enhances CD4+ T-helper and CD8+ cytotoxic T-cell populations, and how it modulates antiviral replication kinetics in tissue culture models. This immune coordination pathway is studied to analyze receptor sensitivity, cellular signaling thresholds, and feedback mechanisms.
In neurobiology and mucosal immunology, the intranasal spray format provides an optimized experimental model for studying localized lymphatic delivery pathways. Researchers evaluate whether mucosal delivery via olfactory or trigeminal nerve pathways facilitates transport to central hypothalamic-pituitary structures or local lymphoid tissue (NALT). This allows the study of neuroimmune axis regulation and cellular migration kinetics without systemic variables.
Each bottle of Thymosin Alpha-1 10mg Spray is manufactured using solid-phase peptide synthesis (SPPS), followed by purification and solution formulation steps. The resulting active peptide is dissolved in a stabilized, buffered aqueous solution calibrated to ensure exact concentration per metered spray activation. Quality control protocols include reverse-phase high-performance liquid chromatography (HPLC) for purity verification and liquid chromatography-mass spectrometry (LC-MS) for molecular identity confirmation.
To preserve the stability of the peptide in solution, Thymosin Alpha-1 Spray should be stored under refrigeration (2°C to 8°C) and protected from light. Because medium-sized peptides can undergo slow oxidation or peptide cleavage in aqueous environments over time, maintaining refrigerated storage and minimizing atmospheric exposure is critical to preserving peptide integrity. Proper handling supports consistent concentration and analytical reproducibility across laboratory protocols.
Scientific interest in Thymosin Alpha-1 continues to expand as researchers seek to characterize its stability, receptor interactions, and transport kinetics. Nevertheless, many aspects of its cellular signaling and epithelial transport remain active areas of scientific inquiry. Ongoing studies continue to refine the understanding of immunomodulatory peptides in biological systems. For this reason, Thymosin Alpha-1 10mg Spray should be regarded as an investigational compound whose primary value lies in advancing scientific knowledge of thymic peptide biology.
Thymosin Alpha-1 10mg Spray is supplied exclusively for laboratory research and analytical applications. It is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary use, or diagnostic purposes.
Telomerase enzyme explained: how TERT and TERC maintain telomeres, why it matters in aging and cancer research, plus RUO peptide sourcing. Read the guide.
KLOW peptide research blend is drawing attention across California's research community. Discover its composition, COA basics, and current evidence limits.
Learn what a peptide bond is, how it forms through dehydration synthesis, and why its structure matters for research peptides. Read the full guide now.
(faqs)
